Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mohamad Fairus Abdul Kadir"'
Publikováno v:
Sains Malaysiana. 50:1935-1946
Brequinar sodium (BQR) is a well-studied inhibitor of the dihydroorotate dehydrogenase (DHODH) enzyme. Both the DHODH and uridine-cytidine kinase 2 (UCK2) enzymes have been reported to be over-expressed in cancer cells to maintain the cells high dema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f66cef8543261e94021251fc08c661e9
https://doi.org/10.17576/jsm-2021-5007-09
https://doi.org/10.17576/jsm-2021-5007-09
Publikováno v:
Current pharmaceutical biotechnology. 21(15)
Background: The re-emerging of targeting Dihydroorotate Dehydrogenase (DHODH) in cancer treatment particularly Acute Myelogenous Leukemia (AML) has corroborated the substantial role of DHODH in cancer and received the attention of many pharmaceutical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10d33f1db251ddd6c44d360bfa0a4bd2
https://pubmed.ncbi.nlm.nih.gov/32525770
https://pubmed.ncbi.nlm.nih.gov/32525770
Autor:
Umarani Subramaniam, Thomas Anthony, Kavitha Nellore, Pratheev Alagapan, Dharvind Balan, Mathura Subangari Dorasamy, Yang Jin Lim, Wai Mun Kong, Mohamad Fairus Abdul Kadir, Sivapriya Marappan, Wesley Roy Balasubramanian
Publikováno v:
Frontiers in Pharmacology. 9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d69b67dad7e711f20926539b2e348587
https://doi.org/10.3389/conf.fphar.2018.63.00017
https://doi.org/10.3389/conf.fphar.2018.63.00017